Comment by wbl 14 hours ago Worth it 4 comments wbl Reply D-Coder 12 hours ago It's a trade-off: better info versus handling an immediate crisis. If it's not an immediate crisis, you can take more time.Engineering is trade-offs. wbl 12 hours ago People are dying of these diseases every day D-Coder 8 hours ago And killing them with an insufficiently tested treatment is not optimal. ryoshoe 12 hours ago For patients. But maybe not to the companies which would have to pay for these large expedited trials
D-Coder 12 hours ago It's a trade-off: better info versus handling an immediate crisis. If it's not an immediate crisis, you can take more time.Engineering is trade-offs. wbl 12 hours ago People are dying of these diseases every day D-Coder 8 hours ago And killing them with an insufficiently tested treatment is not optimal.
wbl 12 hours ago People are dying of these diseases every day D-Coder 8 hours ago And killing them with an insufficiently tested treatment is not optimal.
ryoshoe 12 hours ago For patients. But maybe not to the companies which would have to pay for these large expedited trials
It's a trade-off: better info versus handling an immediate crisis. If it's not an immediate crisis, you can take more time.
Engineering is trade-offs.
People are dying of these diseases every day
And killing them with an insufficiently tested treatment is not optimal.
For patients. But maybe not to the companies which would have to pay for these large expedited trials